BarrettNR. Chronic peptic ulcer of the oesophagus and ‘oesophagitis’. Br J Surg1950; 38:175–182.
2.
AllisonPR, JohnstonAS. The oesophagus lined with gastric mucous membrane. Thorax1953; 8:87–101.
3.
BarrettNR. The lower esophagus lined by columnar epithelium. Surgery1957; 41:881–894.
4.
SpechlerSJ, GoyalRK. Barrett's Esophagus. N Engl J Med1986; 315:362–371.
5.
SkinnerDB, WaltherBC, RiddellRH. Barrett's esophagus: Comparison of benign and malignant cases. Ann Surg1983; 198:554–566.
6.
PaullA, TrierJS, DaltonDD. The histological spectrum of Barrett's esophagus. N Engl J Med1976; 295:476–480.
7.
TrudgrillNJ, SuvarnaSK, KapurKC. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut1997; 41:585–589.
8.
HackelsbergerA, GuntherT, SchultzeV. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease?Gut1998; 43:17–21.
9.
KimSL, WaringP, SpechlerSJ. The Department of Veteran Affairs Gastroesophageal Study Group. Diagnostic inconsistencies in Barrett's esophagus. Gastroenterology1994; 107:945–949.
10.
ToddJA, JohnstonDA. The absence of intestinal metaplasia does not exclude Barrett's oesophagus. Gut1999; 44(Suppl 1):A108
11.
SharmaP, MoralesTG, SamplinerRE. Short segment Barrett's esophagus - the need for standardisation of the definition and of endoscopic criteria. Am J Gastroenterol1998; 93:1033–1036.
12.
CameronAJ, LomboyCT. Barrett's esophagus: Age, prevalence and extent of columnar epithelium. Gastroenterology1992; 103:1241–1245.
13.
HameetemanW, TytgatGN, HouthoffHJ. Barrett's esophagus: Development of dysplasia and adenocarcinoma. Gastroenterology1989; 96:1249–1256.
14.
van der BurghA, DeesJ, HopWCJ. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut1996; 39:5–8.
15.
MirosM, KerlinP, WalkerN. Only patients with dysplasia progress to adenocarcinoma in Barrett's esophagus. Gut1991; 32:1441–1446.
16.
HeitmillerRF, RedmondM, HamiltonSR. Barrett's esophagus with high-grade dysplasia. Ann Surg1996; 224:66–71.
17.
EdwardsMJ, GableDR, AbetLentsch. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg1996; 223:585–591.
18.
GillenP, KeelingP, ByrnePJ. Experimental columnar metaplasia in the canine oesophagus. Br J Surg1988; 75:113–115.
19.
RobertsonD, AldersleyM, ShepherdH. Patterns of acid reflux in complicated oesophagitis. Gut1987; 28:1484–1488.
MarshallREK, AnggiansahA, OwenWA. The temporal relationship between bile reflux and pH in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol1998; 10:385–392.
22.
ParillaP, OrtizA, Martinez de HaroLF. Evaluation of the magnitude of gastro-oesophageal reflux in Barrett's oesophagus. Gut1990; 31:964–967.
GotleyDC, MorganAP, BallD. Composition of gastro-oesophageal refluxate. Gut1991; 32:1093–1099.
26.
NehraD, HowellP, WilliamsCP. Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut1999; 44:598–602.
27.
ChampionG, RichterJE, VaeziMF. Duodenogastric-esophageal reflux: Relationship to pH and importance in Barrett's esophagus. Gastroenterology1994; 107:747–754.
28.
KauerWKH, PetersJH, DeMeesterTR. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. Ann Surg1995; 222:525–533.
29.
KwilaaksoE, FrommD, SilenW. Effect of bile salts and related compounds on isolated esophageal mucosa. Surgery1980; 87:280–285.
30.
HopwoodD, BatesonMC, MilneG. Effect of bile acids and hydrogen ion on the fine structure of oesophageal epithelium. Gut1981; 22:306–311.
31.
BatesonMC, HopwoodD, MilneG. Oesophageal epithelial ultrastructure after incubation with gastrointestinal fluids and their components. J Pathol1980; 133:33–51.
32.
LillemoeKD, JohnsonLF, HarmonJW. Taurodeoxycholate modulates the effects of pepsin and trypsin in experimental oesophagitis. Surgery1985; 97:662–667.
33.
WilmerA, TackJ, FransE. Duodenogastroesophageal reflux and esophageal mucosal injury in mechanically ventilated patients. Gastroenterology1999; 116:1293–1299.
34.
LockeGR, TalleyNJ, FettSL. Prevalence and clinical spectrum of gastroesophageal reflux: A population based study in Olmsted County, Minnesota. Gastroenterology1997; 112:1448–1456.
35.
PrachAT, MacDonaldTA, HopwoodDA. Increasing incidence of Barrett's oesophagus: education, enthusiasm or epidemiology?Lancet1997; 350:933.
36.
WatsonA, ReedPI, CaygillCPJ. Changing incidence of columnar-lined (Barrett's) oesophagus (CLO) in the UK. Gut1999; 44(Suppl 1):A45.
37.
CameronAJ, ZinsmeisterAR, BallardDJ. Prevalence of columnar-lined (Barrett's) esophagus: Comparison of population based clinical and autopsy findings. Gastroenterology1990; 99:918–922.
38.
HirotaWK, LoughneyTM, LazasDJ. Specialised intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology1999; 116:277–285.
39.
Mc KinneyPA, SharpL, MacfarlaneGJ. Oesophageal and gastric cancer in Scotland 1960–90. Br J Cancer1995; 71:411–415.
40.
BlotWJ, DevesaSS, KnellerRW. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA1991; 265:1287–1289.
41.
PowelJ, McConkeyCC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer1990; 62:440–443.
HamiltonSR, SmithRRL, CameronJL. Prevalence and characteristics of Barrett's esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol1988; 19:942–948.
44.
WilliamsonWA, EllisFH, GibbSP. Barrett's esophagus: Prevalence and incidence of adenocarcinoma. Arch Intern Med1991; 151:2212–2216.
45.
Menke-PluymersMBE, HopWCJ, DeesJ. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett's) esophagus. Cancer1993; 72:1155–1158.
46.
van der BurghA, HopWCJ, van BlankensteinM. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut1996; 39:5–8.
47.
Menke-PluymersMBE, SchouteNW, MuldoAH. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut1992; 33:1454–1458.
48.
van SandickJW, van LanschotJJB, KuikenBW. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological and clinical outcome of Barrett's carcinoma. Gut1998; 43:216–222.
49.
CameronAJ, OttBJ, PayneWS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med1985; 313:857–859.
50.
AchharE, CareyW. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Am J Gastroenterol1988; 83:291–294.
51.
SamplinerRE. Practice guidelines on the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol1998; 93:1028–1032.
52.
LevineDS, HaggittRC, BlountPL. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology1993; 105:40–50.
53.
ReidBJ, WeinsteinWM, LevinKJ. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology1988; 94:81–90.
PulliamG, GarewalHS, SamplinerRE. Effect of esophageal location on chemosensitivity to acid in patients with Barrett's esophagus. Gastroenterology1998; 114:A207.
56.
BremnerRM, DeMeesterTR, BremnerCG. Further evidence of altered sensitivity to reflux in patients with Barrett's esophagus. Gastroenterology1996; 110:A640.
57.
SharmaP, MoralesTG, BhattacharyyaA. Squamous islands in Barrett's esophagus: What lies underneath?Am J Gastroenterol1998; 93:332–335.
58.
BiddlestoneLR, BarhamCP, WilkinsonSP. The histopathology of treated Barrett's esophagus. Am J Surg Pathol1998; 22:239–245.
59.
SharmaP, SamplinerRE, CamargoE. Normalisation of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol1997; 92:582–585.
60.
ByrneJP, ArmstrongGR, AttwoodSEA. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. Am J Gastroenterol1998; 93:1810–1815.
61.
KatzdaDA, CastellDO. Successful elimination of reflux symptoms does not ensure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol1994; 89:989–991.
62.
SaloJA, SalominenJT, KiviluotoTA. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann Surg1998; 227:40–44.
63.
McCallumRW, PolepalleS, DavenportK. Role of anti reflux surgery against dysplasia. Gastroenterolgy1991; 100:A121.
64.
OrtizA, Martinez de HaroLF, ParrillaP. Conservative treatment versus antireflux surgery in Barrett's oesophagus: Long-term results of a prospective study. Br J Surg1996; 83:274–278.
65.
McDonaldML, TrastekVF, AllenMS. Barrett's esophagus: Does an antireflux procedure reduce the need for endoscopic surveillance?J Thorac Cardiovasc Surg1996; 111:1135–1139.
